IVF Stock Risk & Deep Value Analysis
INVO Fertility Inc
Healthcare • Medical Devices
DVR Score
out of 10
What You Need to Know About IVF Stock
We analyzed INVO Fertility Inc using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran IVF through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Aggressive. Here's what we found.
How Risky Is IVF Stock?
Overall Risk
Aggressive
Financial Risk
High
Market Risk
High
Competitive Risk
High
Execution Risk
High
Regulatory Risk
Medium
What Are the Red Flags for IVF?
- âš
Failure to secure additional funding, leading to cessation of operations
- âš
Official delisting of shares from public exchange
- âš
Further deterioration of cash position and increasing debt
- âš
Adverse regulatory action or competitive pressure leading to market share loss
Unlock IVF Red Flags & Risk Warnings
Create a free account to see the full analysis
What Does INVO Fertility Inc (IVF) Do?
Market Cap
$3.63M
Sector
Healthcare
Industry
Medical Devices
Employees
33
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. In addition, the company develops NY-303, a GPC3 x NKp46 bifunctional antibody that is in Phase i/ii a monotherapy trial for the treatment of hepatocellular carcinoma; and NY-500, an AI-optimized bifunctional antibody. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.
Visit INVO Fertility Inc WebsiteIs IVF Stock Undervalued?
Unlock the full AI analysis for IVF
Get the complete DVR score, risk analysis, and more
Does IVF Have a Competitive Moat?
Sign in to unlockMoat Rating
⚪ None
Moat Trend
Eroding
Moat Sources
1 Identified
The company's severe financial distress and lack of operational capital are rapidly eroding any potential moat from its technology or IP. Without capital, IP becomes vulnerable and cannot be defended or commercialized effectively.
Moat Erosion Risks
- •Insolvency and liquidation of assets
- •Lack of funding to develop or protect IP
- •Competitors developing alternative or superior technologies
- •Inability to scale production or distribution
IVF Competitive Moat Analysis
Sign up to see competitive advantages
What Could Drive IVF Stock Higher?
Near-Term (0-6 months)
- •Announcement of successful, substantial non-dilutive financing (highly unlikely without significant operational improvements)
- •Potential notice of delisting from NASDAQ due to non-compliance
- •Bankruptcy proceedings or restructuring announcement
Medium-Term (6-18 months)
- •Acquisition by a larger pharmaceutical or medical device company (highly speculative)
- •Major strategic partnership that provides significant capital and distribution (unlikely given current state)
Long-Term (18+ months)
- •N/A - Company's long-term viability is uncertain under current conditions
Catalysts & Growth Drivers
Upgrade to Premium to see catalysts
What's the Bull Case for IVF?
- ✓
Announcement of substantial new equity or debt financing (positive)
- ✓
Official notice of delisting from NASDAQ (negative)
- ✓
Any concrete revenue generation or significant operational milestones (positive)
- ✓
Bankruptcy filing (negative)
Bull Case Analysis
See what could go right with Premium
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for IVF (INVO Fertility Inc) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.
